|
CINC
|
CinCor Pharma, Inc.
|
US
|
NASDAQ
|
|
CLGN
|
CollPlant Holdings, Ltd.
|
US
|
NASDAQ
|
|
CLNN
|
Clene Inc.
|
US
|
NASDAQ
|
|
CNCE
|
Concert Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CO
|
China Cord Blood Corporation
|
US
|
NYSE
|
|
COEP
|
Coeptis Therapeutics Holdings, Inc
|
US
|
NASDAQ
|
|
CRL
|
Charles River Laboratories International, Inc.
|
US
|
NYSE
|
|
CRVS
|
Corvus Pharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
CTLT
|
Catalent, Inc.
|
US
|
NYSE
|
|
CTMX
|
CytomX Therapeutics, Inc.
|
US
|
NASDAQ
|
|
CUE
|
Cue Biopharma, Inc.
|
US
|
NASDAQ
|
|
CWBR
|
CohBar, Inc.
|
US
|
NASDAQ
|
|
CYAD
|
Celyad SA
|
US
|
NASDAQ
|
|
DICE
|
DICE Therapeutics, Inc.
|
US
|
NASDAQ
|
|
DMAC
|
DiaMedica Therapeutics Inc.
|
US
|
NASDAQ
|
|
DNA
|
Ginkgo Bioworks Holdings, Inc.
|
US
|
NYSE
|
|
DYAI
|
Dyadic International, Inc.
|
US
|
NASDAQ
|
|
EIGR
|
Eiger BioPharmaceuticals, Inc.
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
US
|
NYSE
|
|
ELEV
|
Elevation Oncology, Inc.
|
US
|
NASDAQ
|